Brief: Kalaris Reports Second Quarter 2025 Financial Results And Provides Business Updates
13/08/2025 14:00
Aug 13 (Reuters) - Kalaris Therapeutics Inc KLRS.O: KALARIS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES KALARIS THERAPEUTICS INC - CASH & CASH EQUIVALENTS OF $88.4M AS OF JUNE 30, 2025, EXPECTED TO FUND OPERATIONS INTO Q4 2026 KALARIS THERAPEUTICS INC - NET LOSS $11.4M OR $0.61/SHARE IN Q2 2025 Source text: ID:nGNXbpk9rP Further company coverage: KLRS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million